Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright’s 26th Annual Global Investment Conference September 9-11
26 août 2024 09h00 HE
|
Firefly Neuroscience, Inc.
TORONTO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions...
Aviv Clinics Congratulates Peter Paltchik on Winning Bronze at the 2024 Paris Olympics
22 août 2024 09h00 HE
|
Aviv Clinics
ORLANDO, Fla., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Aviv Clinics, one of the most advanced brain and performance clinics in the world, congratulates Peter Paltchik on his bronze medal win in the Men’s...
Firefly Neuroscience, an AI-Driven Brain Health Company, to Host Shareholder Update Call on September 4th
22 août 2024 09h00 HE
|
Firefly Neuroscience, Inc.
TORONTO, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) technology company developing innovative...
Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management for Patients with Cognitive Disorders
21 août 2024 09h00 HE
|
Firefly Neuroscience, Inc.
TORONTO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) technology company developing innovative...
DiagnaMed Expands with Drug and Clinical Research AI Platform
21 août 2024 08h00 HE
|
DiagnaMed Holdings Corp.
Leveraging proprietary EEG data from previous and future research studies with BRAIN AGE® Brain Health AI Accelerating clinical trial development and discovering potential novel treatments for...
DiagnaMed Offering its Brain Health AI Platform for Investigating Weight Loss Drugs, such as Semaglutide (GLP-1), on Brain Function
15 août 2024 08h00 HE
|
DiagnaMed Holdings Corp.
TORONTO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, is...
UPDATE -- Firefly Neuroscience CEO Issues Letter to Stockholders Following Closing of Merger and Listing on Nasdaq
13 août 2024 16h06 HE
|
Firefly Neuroscience, Inc.
Firefly Neuroscience CEO Issues Letter to Stockholders
Following Closing of Merger and Listing on Nasdaq
AFS Introduces MycoThrive™ Lion's Mane: A Clinically Studied Ingredient for Cognitive Performance
13 juil. 2024 12h55 HE
|
Applied Food Sciences, Inc.
Kerrville, Texas, July 13, 2024 (GLOBE NEWSWIRE) -- Applied Food Sciences (AFS) is proud to announce the launch of MycoThrive™ Lion's Mane, a groundbreaking functional ingredient recently clinically...
Clearday Supports National Health Observances
12 juin 2024 16h00 HE
|
Clearday, Inc.
San Antonio, TX, June 12, 2024 (GLOBE NEWSWIRE) -- Clearday (OTC- CLRD), supports the post on May 29, 2024, from the Office of Disease Prevention and Health Promotion. Said office features monthly...
Inaugural Dementia Conference in Africa, Convened by Nature, Davos Alzheimer’s Collaborative, and Aga Khan University, to Advance Lifespan Brain Health Innovations Across Diverse Communities
16 mai 2024 08h54 HE
|
Davos Alzheimer's Collaborative
Geneva, Switzerland, May 16, 2024 (GLOBE NEWSWIRE) -- Researchers, policymakers, and industry leaders from the global south will convene to showcase Africa’s unique brain health and dementia...